Characterizing and Reducing New Persistent Opioid Use in Patients Undergoing Complex Major Surgery
Characterizing and Reducing New Persistent Opioid Use in Patients Undergoing Complex Major Surgery
批准号:
10065067
负责人:
Craig Brown
金额:
$7.38万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2022-06-30
关键词:
AbateAcute PainAddressAdmission activityBlood VesselsBlue CrossBlue ShieldCaringCenters for Disease Control and Prevention (U.S.)CharacteristicsComplexConsumptionContinuity of Patient CareCountryDataDatabasesDevelopmentEpidemicExcisionExposure toFamily memberGuidelinesGynecologic Surgical ProceduresHospitalsHydrocodoneIndividualInstitutionInterventionInterviewInvestigationLength of StayLungMeasuresMichiganMorbidity - disease rateOperative Surgical ProceduresOpiate AddictionOpioidOpioid AnalgesicsOutpatientsOxycodonePainPain managementPathway interactionsPatient CarePatient Outcomes AssessmentsPatientsPatternPeer PressurePlayPostoperative PainPostoperative PeriodPredictive FactorPreparationPrescription drug overdosePrescription opioid overdoseProceduresPublic HealthRecoveryReportingResearch ProposalsRoleSamplingStructureSupport SystemSurgeonSurgical complicationSystemTreatment EfficacyUniversitiesWorkchronic painchronic pain managementcopingdepressive symptomsdesignevidence baseheroin usehigh riskhigh risk populationimprovedinterestmortalityoperationopioid epidemicopioid exposureopioid mortalityopioid useprescription opioidpreventprogramspsychologicskills
中文摘要
摘要
阿片类药物的流行是一场公共卫生危机,由于药物滥用,
在过去的二十年里,无意的处方阿片类药物过量增加了450%。尽管主要
慢性疼痛管理和慢性疼痛阿片类药物处方实践的进展,
急性疼痛的处方并未减少。此外,外科手术后的阿片类药物处方
是新的持续性阿片类药物使用的共同进入途径。我们之前的研究显示,
在多种常见门诊手术后患者中新的持续阿片类药物使用,但
对重大外科手术后的病人和那些患有并发症的病人进行调查,
缺乏程序。术后病程复杂的患者往往要反复进行手术
并延长了住院时间,改变了他们疼痛减轻的轨迹,
这大大增加了他们在医院内外接触术后阿片类药物的机会。
在这项研究计划中,我们将重点收集来自几个全州数据库的数据,包括
通过密歇根外科质量合作组织(MSQC)和Blue
Cross Blue Shield of Michigan(BCBSM)调查新的持续使用阿片类药物的程度
在复杂手术患者中的发展。此外,我们将定义术后
阿片类药物暴露在新的持续阿片类药物使用的发展中起作用,以及哪些患者水平因素是预测因素
新的阿片类药物依赖的风险。最后,我们将利用这些发现来开发,
为接受复杂外科手术的患者实施和评估循证疼痛计划。
英文摘要
Abstract
The opioid epidemic represents a public health crisis that continues to worsen with mortality due to
unintentional prescription opioid overdose increasing by 450% over the last two decades. Despite major
advancements in the management of chronic pain and opioid prescription practices for chronic pain,
prescriptions for acute pain have not declined. Additionally, opioid prescriptions following surgical operations
represent a common entry pathway to new persistent opioid use. Our previous work has shown high rates of
new persistent opioid use among patients following multiple common outpatient surgical procedures, but
investigation into patients after major surgical operations and those that suffer complications from those
procedures is lacking. Patients with complicated post-operative courses often undergo repeated procedures
and have prolonged lengths of hospital stay, altering the trajectory with which their pain abates and potentially
drastically increasing their exposure to post-operative opioid medications both in an out of the hospital.
In this research proposal, we will focus on gathering data from several statewide databases including those
available through the partnership between the Michigan Surgical Quality Collaborative (MSQC) as well as Blue
Cross Blue Shield of Michigan (BCBSM) to investigate the magnitude of new persistent opioid use
development among patients having complex surgery. In addition, we will define the role that post-operative
opioid exposure plays in development of new persistent opioid use and what patient level factors are predictive
of new opioid dependency in this high-risk group of patients. Finally, we will utilize these findings to develop,
implement and assess an evidence-based pain plan for patients undergoing complex surgical procedures.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/jaha.121.023356
发表时间:
2022-11-15
期刊:
JOURNAL OF THE AMERICAN HEART ASSOCIATION
影响因子:
5.4
作者:
[Brown, Craig S., Eton, Ryan E., Yaser, Jessica M., Syrjamaki, John D., Corriere, Matthew A., Henke, Peter K., Englesbe, Michael J., Osborne, Nicholas H.]
通讯作者:
Osborne, Nicholas H.
DOI:
10.1016/j.jvs.2021.01.061
发表时间:
2021-09
期刊:
Journal of vascular surgery
影响因子:
4.3
作者:
[Brown CS, Smith ME, Kim GY, Sutzko DC, Henke PK, Corriere MA, Siracuse JJ, Goodney PP, Osborne NH]
通讯作者:
Osborne NH
CT-measured Cortical Volume Ratio Is an Accurate Alternative to Nuclear Medicine Split Scan Ratio Among Living Kidney Donors.
CT 测量的皮质体积比是活体肾脏捐赠者中核医学分裂扫描比的准确替代方案。
DOI:
10.1097/tp.0000000000003676
发表时间:
2021
期刊:
Transplantation
影响因子:
6.2
作者:
[Montgomery,JohnR, Brown,CraigS, Zondlak,AllyseN, Walsh,KevinW, Kozlowski,JuliaE, Pinsky,AlexaM, Herriman,EmilyA, Sussman,Jeremy, Lu,Yee, Stein,EricaB, Shankar,PrasadR, Sung,RandallS, Woodside,KennethJ]
通讯作者:
Woodside,KennethJ
Introduction to the Best-Case/Worst-Case Framework Within Transplantation Surgery to Improve Decision-Making for Increased Risk Donor Organ Offers.
介绍移植手术中的最佳情况/最坏情况框架,以改善增加风险的供体器官供应的决策。
DOI:
10.1177/1526924820958116
发表时间:
2020
期刊:
Progress in transplantation (Aliso Viejo, Calif.)
影响因子:
--
作者:
[Highet,Alexandra, Cassidy,DevonE, Gomez-Rexrode,AmaliaE, Kirsch,MichaelJ, Eton,Ryan, Brown,CraigS, Waits,SethA, Englesbe,MichaelJ]
通讯作者:
Englesbe,MichaelJ
DOI:
10.1097/sla.0000000000004965
发表时间:
2022-12-01
期刊:
Annals of surgery
影响因子:
9
作者:
[Howard R, Brown CS, Lai YL, Gunaseelan V, Chua KP, Brummett C, Englesbe M, Waljee J, Bicket MC]
通讯作者:
Bicket MC
共 11 条
海外基金